Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Collective

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Collective head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 44 · Grade C

Collective

Visit Collective Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 79 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Collective a bad call — it's best for readers comfortable paying an annual membership in addition to the medication charge who confirm their state is served. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
64
Supply Reliability
95
82
Transparency
90
80
Access Breadth
93
90
Clinical Oversight
92
91
Track Record
88
76
CoreAge RxBrief Score 94 · 79Collective

Price, coverage & the tracker

CoreAge RxCollective
Brief Score94/100 (A)79/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

From $59/mo (all doses, plus a separate fee, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

From $69/mo (all doses, plus a separate fee, compounded)

CoverageUS only; restrictions by state, confirmed at intake44 states; excludes AL, CA, LA, MA, MS and WA per provider, checked October 6, 2026
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Collective: Medication costs $59 per month for semaglutide or $69 for tirzepatide, plus a required $199 annual membership. The 21-day membership trial does not make medication free.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.